Navigation Links
Oncolytics Biotech Inc. Announces Publication of Research on Combination Reovirus and Radiation Therapy
Date:2/3/2008

CALGARY, Feb. 4 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) ('Oncolytics') reported today that Dr. Kevin Harrington and his research group at The Institute of Cancer Research, London, U.K. published the results of their work testing combination treatment schedules of reovirus and radiation in human and murine tumour cells in vitro and in vivo. The paper, entitled "Enhanced In vitro and In vivo Cytotoxicity of Combined Reovirus and Radiotherapy" appears online in the February 1, 2008 issue of Clinical Cancer Research.

The effect of different schedules of reovirus and radiotherapy on viral replication and cytotoxicity was tested in vitro and the combination was assessed in three tumour models in vivo. The results demonstrated that combining reovirus and radiotherapy significantly increased cancer cell killing both in vitro and in vivo, particularly in cell lines with moderate susceptibility to reovirus alone.

"Dr. Harrington's work demonstrates convincingly that REOLYSIN(R) works to enhance the effects of radiation therapy," said Dr. Matt Coffey, Chief Scientific Officer of Oncolytics. "The results of this preclinical research provided strong support for the combination REOLYSIN(R) and radiation clinical trials we are conducting in the U.K. To date, we have successfully completed enrolment in a Phase Ia/Ib combination REOLYSIN(R) and radiation trial and are currently enrolling patients in a Phase II trial using this combination."

About Oncolytics Biotech Inc.

Oncolytics is a Calgary-based biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics. Oncolytics' clinical program includes a variety of Phase I and Phase II human trials using REOLYSIN(R), its proprietary formulation of the human reovirus, alone and in combination with radiation or chemotherapy. For further information about Oncolytics, please visit

SOURCE Oncolytics Biotech Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Oncolytics Biotech Inc. Announces Issuance of 23rd U.S. Patent
2. Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
3. Media Advisory - Oncolytics Biotech Inc. to Present at BioPartnering Europe
4. Media Advisory - Oncolytics Biotech Inc. to Present at BIO InvestorForum 2007
5. Oncolytics Biotech Inc. Announces Approval for U.K. Clinical Trial Investigating REOLYSIN(R) in Combination with Cyclophosphamide
6. Oncolytics Biotech Inc. Collaborators to Present Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
7. Oncolytics Biotech Inc. Announces 2007 Third Quarter Results
8. Media Advisory - Oncolytics Biotech Inc. to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
9. Media Advisory - Oncolytics Biotech Inc. to Present at Toronto CFA Society
10. Oncolytics Biotech Inc. Announces Issuance of 24th U.S. Patent
11. Oncolytics Biotech Inc. to Present at Annual Vaccine Production Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)..., , MANILA, Philippines, Dec. 2 /PRNewswire... fastest growing green energy companies on the pla...p and True Green Planet,s President and Recycling ...ycling business for over 25 years, stated that Spe...and is setting the stage for spectacular earnings ...
(Date:12/2/2009)..., , COPENHAGEN, Dec. 2 Th... with BioIsoprene technology, a breakthrough alter...dient in the manufacture of synthetic rubber with ... Denmark, this week. One tire will be on display a...enhagen International Airport throughout December ...
(Date:12/2/2009)..., , CAMBRIDGE, Mass., Dec. 2 /PRNews...ther the leaders in technology development and pro...nd MEMS, announced the December 11th deadline for ..., Now in its 14th year, TechConnect World, in a...stitute (NSTI), and the Clean Technology and Susta...
(Date:12/2/2009)..., , QUEBEC CITY, Dec. 2 /PRNewswire-FirstC... AEZ) (the "Company"), a global biopharmaceutical ... today announced that the U.S. Food and Drug Admin... for the Company,s PI3K/Akt pathway inhibitor comp...relapsed/refractory multiple myeloma. Keryx Biopha...
Breaking Biology Technology:Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 3The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 2The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 3Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 3AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3
..., a,leading provider of innovative technologies an...facturing, announced today that it has secured a n...rovide for additional,capital investment in its ne...ntends to begin offering commercial manufacturing ...go: http://www.newscom.com/cgi-bin/prnh/20020925/...
...ions will worsen the dual environmental crises of ...orests are better protected, warn scientists in th.... , Lead author, Emily Fitzherbert from the Zoolo...lia said: "There has been much debate over the rol... and its impacts on biodiversity. We wanted to put...
...ing a safe supply of drinking water for regions of...ater contamination is rife. Writing in the Intern...ers in India explain how carbon nanotubes could re... systems. , Water shortages and lack of access to...r global problems. At present, more than one billi...
Other Biology Technology:Althea Technologies Secures $12 M Credit Line to Continue Facility Growth and Expansion 2Oil palm plantations are no substitute for tropical rainforests, a new study shows 2Oil palm plantations are no substitute for tropical rainforests, a new study shows 3Water purification down the nanotubes 2
(Date:12/3/2009)...N.M. Most scientists believe that staph infection...ach other to emit toxins. The signaling process is...be present to start the process. , But the Jeff ...y first stage of staph infection, when bacteria sw... a single cell and that this individual process ca...
(Date:12/3/2009)... can undergo a personality change in warmer water,...hat climate change may make some species more aggr...damselfish on Australia,s Great Barrier Reef have ...ither consistently timid, or consistently bold, an...marked as water temperatures rise. , A slight li...
(Date:12/3/2009)... must be included in the design of the upcoming fo...tarian crisis, according to a scientist at the Uni...Dr Simon Lewis argues that at least 50% of the car...own as REDD (Reducing Emissions from Deforestation...rs directly, and their property rights assured. ,...
Breaking Biology News(10 mins):Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 3Fish with attitude: Some like it hot 2Forest deal at Copenhagen must avoid creating 'carbon refugees' 2Sigma Aldrich 28Nasdaq 3A SIAL 29 Declares Quarterly Dividend 14787 1Statins May Stave Off Gallstones 61097 1Statins May Stave Off Gallstones 61097 2Statins May Stave Off Gallstones 61097 3The Revolving Door of Heart Failure Hospitalization 61094 1The Revolving Door of Heart Failure Hospitalization 61094 2The Revolving Door of Heart Failure Hospitalization 61094 3
...ed to help monitor the health of Florida,s coral r...his August and September. , The project was the f... reefs along the entire National Marine Sanctuary ...to the Dry Tortugas in the Florida Keys. Scientist...ient to environmental changes and impacts. The wor...
...cientists has published the first two genome seque...alled Phytophthora--a name that literally means "p...s-like Phytophthora (pronounced "fy-TOFF-thor-uh")...the agriculture, forestry and nursery industries h...hough Phytophthora are similar to fungi, most fung...
...with mental illness goes hand-in-hand with enlarge...ons, researchers at UT Southwestern Medical Center... have found. , The region of the brain called t...s in humans who carry the gene. , "This might ... from the pulvinar are more strongly influenced in...
Other Biology News:NASA satellite data helps assess the health of Florida's coral reef 2NASA satellite data helps assess the health of Florida's coral reef 3Genome info from 'plant destroyers' could save trees, beans and chocolate 2Gene linked with mental illness shapes brain region, researchers find 2
Goat Anti-Laminin gamma-2 (G-16) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Cell Proliferation Kit from GE Healthcare, formerly Amersham Biosciences
Goat Anti-Human Dysadherin 2 Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Goat Anti-Human Bcl-2, phospho (Thr74) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Biology Products: